Provider profile · Membership plus medication

Hers review: services, costs, and questions

Hers' weight-loss care offer, separate membership and medicine costs, and product-specific safety questions.

Sources checked · Official page retrieved · Medical review pending

A teal laptop, a burgundy folder, a blank receipt, and an envelope on a desk.
Care and costs, illustrated. This is not a photograph of a listed provider or service.
Evidence boundary: This is a review of public information, not a hands-on treatment assessment. We have not independently audited pharmacies, clinician credentials, response times, or patient outcomes. We do not assign a star rating.

What the official information says

The official Hers page describes a weight-loss membership and treatment options assessed by a clinician. It is part of the Hims & Hers group, but enrollment, product choices, and billing should be checked against the specific Hers offer.

A program marketed to women should still identify the exact medicine and formulation. Pregnancy, contraception, and breastfeeding need a clinician-led discussion; marketing about personalization does not replace product-specific safety labeling.

Sources: Hers weight-loss program

Pricing and the full bill

The advertised membership is $39 for the first month, automatically renewing at $149 per month, separately from medication. Confirm whether any quoted medicine price is dose-specific or requires a longer commitment, and obtain the total ongoing bill before paying.

A first-month price is not a reliable annual budget. Ask for the amount charged today, the renewal interval, the cost after any promotion, and whether medication, supplies, visits, labs, and shipping are included. Obtain cancellation and refund terms before paying, particularly if a prescription has not yet been approved.

Sources: Hers weight-loss program

Limitations that affect your decision

Approved and compounded medicines are different regulatory categories. A compounded tablet cannot inherit approved oral Wegovy evidence merely because both mention semaglutide.

Tirzepatide and Foundayo have product-specific oral contraceptive precautions. Do not assume that one safety rule covers every medicine offered through a platform.

Medication trials evaluate specific formulations, doses, and study populations. A provider advertising semaglutide or tirzepatide has not thereby demonstrated that its own treatment produces the results of Wegovy or Zepbound trials. A compounded medicine is not FDA-approved and should not be described as an approved generic equivalent.

Sources: FDA concerns with unapproved GLP-1 drugs used for weight loss · FDA clarification of compounding policies as GLP-1 supply stabilizes

Questions to ask before enrollment

  • Which product's pregnancy and contraceptive instructions apply to my prescription?
  • What are the medication and membership cancellation rules separately?
  • What exact medicine, formulation, and device would I receive, and which pharmacy dispenses it?
  • Who prescribes in my state, and how do I obtain urgent clinical help?
  • What will I pay at maintenance, and when do renewals and cancellation deadlines occur?

Ask the prescribing clinician how your other medicines, diabetes treatment, pregnancy plans, gastrointestinal history, and follow-up needs affect eligibility. Check the dispensing pharmacy with the relevant state board. A reassuring website or testimonial does not replace those checks.

Sources: FDA concerns with unapproved GLP-1 drugs used for weight loss